Questions about this study?
The HopeStage team will email you.
Get research updatesThis historical record does not confirm current site availability.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
This is historical registry information. What is the current study status and protocol?
An Open Label Pilot Study of Atomoxetine Hydrochloride in Adolescents with Attentioin-Deficit/Hyperactivity Disorder and Comorbid Cannabis Abuse
The HopeStage team will email you.
Netherlands
A listed location does not confirm current availability.
The study sponsor is Eli Lilly Nederland.
The historical registry lists this study as terminated.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me